Cargando…
Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo
Clostridioides difficile is a leading cause of antibiotic-associated diarrhea and nosocomial infection in the United States. The symptoms of C. difficile infection (CDI) are associated with the production of two homologous protein toxins, TcdA and TcdB. The toxins are considered bona fide targets fo...
Autores principales: | Kordus, Shannon L., Kroh, Heather K., Rodríguez, Rubén Cano, Shrem, Rebecca A., Peritore-Galve, F. Christopher, Shupe, John A., Wadzinski, Brian E., Lacy, D. Borden, Spiller, Benjamin W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621975/ https://www.ncbi.nlm.nih.gov/pubmed/37871122 http://dx.doi.org/10.1371/journal.ppat.1011496 |
Ejemplares similares
-
Lectin Activity of the TcdA and TcdB Toxins of Clostridium difficile
por: Hartley-Tassell, Lauren E., et al.
Publicado: (2019) -
Inhibition of Clostridioides difficile Toxins TcdA and TcdB by Ambroxol
por: Heber, Sebastian, et al.
Publicado: (2022) -
CdtR Regulates TcdA and TcdB Production in Clostridium difficile
por: Lyon, Shelley A., et al.
Publicado: (2016) -
Inhibition of Clostridium difficile TcdA and TcdB toxins with transition state analogues
por: Paparella, Ashleigh S., et al.
Publicado: (2021) -
A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile
por: Zhang, Bao-Zhong, et al.
Publicado: (2016)